| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 06/13/1995 | US5424463 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 06/13/1995 | US5424462 Method for producing (+)-estrone derivatives |
| 06/08/1995 | WO1995015166A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 06/08/1995 | CA2177848A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 06/07/1995 | EP0655916A1 Transdermal application agent containing 3-keto-desogestrel |
| 06/01/1995 | WO1995014791A1 Design of drugs involving receptor-ligand-dna interactions |
| 06/01/1995 | CA2177388A1 Design of drugs involving receptor-ligand-dna interactions |
| 05/31/1995 | EP0655071A1 METHOD OF PREPARING 1-METHYL-3-KETO--g(D)?1,4 -STEROIDS. |
| 05/24/1995 | DE4343054C1 Prim. or sec. alcohol or 1,2-di:ol oxidn. to aldehyde, ketone, alpha-ketol or alpha-di:ketone |
| 05/23/1995 | US5418228 Contraceptive regimen |
| 05/18/1995 | WO1995013287A1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 05/18/1995 | WO1995013076A1 Use of steroids with a phenolic a-ring structure for prophylaxis and therapy of radical-mediated cell damage |
| 05/18/1995 | CA2176368A1 New steroids with radicophilic substituents, a process for manufacturing these, and medications that contain these compounds |
| 05/11/1995 | WO1995012402A1 Estrogen compositions and method for neuroprotection |
| 05/10/1995 | EP0651643A1 17-ALKYLKETONE STEROIDS USEFUL AS 5-$g(a)-REDUCTASE INHIBITORS |
| 05/10/1995 | CN1102529A Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
| 05/03/1995 | EP0650521A1 Determination of estradiol by competitive immunoassay |
| 05/03/1995 | EP0650495A1 Improved antiandrogens |
| 04/26/1995 | CN1101916A Compounds |
| 04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
| 04/26/1995 | CN1101914A Compounds |
| 04/20/1995 | WO1995010527A1 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use |
| 04/20/1995 | WO1995010284A1 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 04/19/1995 | EP0648779A2 New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | CN1101649A Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical |
| 04/19/1995 | CN1101648A Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical |
| 04/18/1995 | US5407928 Progesterone antagonist suitable for inducing labor or an abortion |
| 04/12/1995 | EP0528876B1 2-iodo-3-keto-delta 4 -steroids, process for producing them and their further processing |
| 04/11/1995 | US5405979 Stereoselectively reducing phenyl-substituted estradiene with electropositive metal in electron-solvating solvent, cleaving ketone protective group with acid |
| 04/11/1995 | US5405944 Glycosides of catechol estrogens |
| 04/06/1995 | CA2133281A1 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibitingcomposition containing the conjugate or estradiol derivative |
| 04/05/1995 | EP0646592A1 Estradiol derivative-alkylating agent conjugate |
| 03/29/1995 | CN1100729A Trifluoromethyl steroids and the prepn. method |
| 03/22/1995 | EP0643581A1 Ocular androgen therapy in sjögren's syndrome |
| 03/21/1995 | CA1334844C 9-alpha-hydroxysteroids, process for their preparation, process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids |
| 03/16/1995 | WO1995007081A1 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen |
| 03/16/1995 | DE4330237A1 1-Methyl-substituted androsta-1,4-diene-3,17-diones, process for the preparation thereof and pharmaceutical products containing them |
| 03/15/1995 | EP0643070A1 Steroid intermediates and process for their preparation |
| 03/15/1995 | EP0573604B1 Methods for the treatment of osteoporosis |
| 03/15/1995 | CN1100101A 14alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same |
| 03/09/1995 | WO1995006474A1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/09/1995 | WO1995006472A1 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 03/09/1995 | DE3590020C2 1-Hydroxy-vitamin-D compounds which are unsaturated in the side chain |
| 03/09/1995 | CA2148373A1 Delta 5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 03/08/1995 | EP0641355A1 Steroid sulphatase inhibitors |
| 03/08/1995 | EP0641211A1 INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY |
| 03/08/1995 | CN1099758A New preparation process for 6alpha, 9alpha-difluorinated steroids and new intermediates |
| 03/07/1995 | US5395842 Inhibitors of sex steroids |
| 03/07/1995 | US5395831 Atherosclerosis and osteoporosis treatment |
| 03/07/1995 | CA1334668C 13-alkyl-11beta-phenylgonanes |
| 03/02/1995 | WO1995005827A1 Agent for transdermal application containing gestoden esters |
| 03/02/1995 | CA2170371A1 Agent for transdermal administration that contains gestodene esters |
| 02/28/1995 | US5393785 Therapeutic antiestrogens |
| 02/21/1995 | US5391778 2-iodo-3-keto-Δ4 steroids, process for their production, as well as their further processing |
| 02/21/1995 | US5391776 Steroid derivatives |
| 02/16/1995 | WO1995004535A1 Estrogenic compounds as anti-mitotic agents |
| 02/15/1995 | EP0638090A1 17$g(a) AND 17$g(b)-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID |
| 02/15/1995 | EP0637915A1 Compositions and methods for regulating il-6 production in vivo |
| 02/09/1995 | WO1995004283A1 Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 02/09/1995 | WO1995004070A1 15,15-dialkyl-substituted derivatives of estradiol |
| 02/09/1995 | CA2168657A1 15,15-dialkyl-substituted derivatives of estradiol |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/01/1995 | EP0636138A1 Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
| 01/26/1995 | WO1995002607A1 7-SUBSTITUTED-Δ4-6-AZASTEROID DERIVATIVES AS 5α-REDUCTASE INHIBITORS |
| 01/25/1995 | CN1097763A Trifluoro-methyl steroid, preparation and its application |
| 01/12/1995 | WO1995001366A1 Fluorinated 6-methylenandrosta-1,4-dien-3-one derivatives and process for their preparation |
| 01/04/1995 | CN1027270C 14,17 beta-ehano-14 beta-estratrienes and estratetranenes, process for their production and pharmaceutical preparations containing them |
| 01/03/1995 | US5378611 Process for producing 6β,14α-dihydroxy-4-androstene-3, 17-dione amid 14α-hydroxy-4-androstene-3,6,17-trione from 4-androstene-3, 17-dione using myrothecium sp. ferm bp-4432 |
| 12/28/1994 | EP0630246A1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 12/22/1994 | WO1994028904A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 12/22/1994 | WO1994028903A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 12/22/1994 | CA2165325A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 12/22/1994 | CA2165324A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/21/1994 | CN1096443A Anti-atherosclerotic use of 17 alpha-dihydroeoquilin |
| 12/20/1994 | US5374732 Chemical intermediates as fluorination agents |
| 12/20/1994 | CA1333597C 16,17-acetalsubstituted androstane-17.beta.-carboxylic acid esters |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
| 12/15/1994 | DE4319998A1 Process for the preparation of derivatives of oestra-1,3,5(10),14-tetraene-3,17 alpha -diol |
| 12/14/1994 | EP0628052A1 Alkali metal 8,9-dehydroestrone sulfate esters |
| 12/13/1994 | US5372996 Method of treatment of androgen-related diseases |
| 12/08/1994 | WO1994027609A1 Dihydrotestosterone for use in androgenotherapy |
| 11/30/1994 | EP0626388A2 14Alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same |
| 11/29/1994 | CA2124382A1 14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same |
| 11/24/1994 | WO1994026767A1 Improved antiandrogens |
| 11/24/1994 | WO1994016709A3 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 11/24/1994 | CA2136303A1 Improved antiandrogens |
| 11/23/1994 | EP0532562B1 PROCESS FOR PRODUCING 10$g(b)-H-STEROIDS |
| 11/23/1994 | CN1095418A Process for production of 6beta,14alpha-dihydroxy-4-androstene-3,17-dione |
| 11/23/1994 | CN1095382A Compounds |
| 11/17/1994 | EP0624162A1 Novel steroid intermediates and processes for their preparation |
| 11/16/1994 | CN1095071A Compounds |
| 11/15/1994 | US5364847 Inhibitors of sex steroid biosynthesis and methods for their production and use |
| 11/15/1994 | US5364531 Process for affinity purification by immunoadsorption in non-aqueous solvent |
| 11/09/1994 | EP0464153B1 Dehalogenation of organic compounds using tin or lead |
| 11/02/1994 | EP0621866A1 Process for preparing 3-acylestratrienes and acylbenzenes |
| 10/27/1994 | WO1994024146A1 Novel androgens and anabolic agents |
| 10/26/1994 | CN1026324C 11beta-(4-isopropenylbenzene)-4,9-estrobiene, preparation of same and pharmaceutical containing same |
| 10/25/1994 | US5359071 15-substituted 4-azasteroids |
| 10/25/1994 | CA1332734C Natriuretic hormone |